drugset / Trial / NCT00960245
Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to demonstrate the relative bioavailability of Nadolol (1 x 80 mg) tablets under fasting conditions.
Timeline
- Start
- 1994-07
- Primary completion
- 1994-07
- Completion
- 1994-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Corgard | Unknown | 80 mg | — |
| Subject | Nadolol | Unknown | 80 mg | — |